Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-055146

Chief Financial Officer sold 739 shares at $12.88 ($9,519)

  • Chief Financial Officer acquired 2,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-30 Exercise or conversion : show line 1 in the form +2,886 75,542 D
2022-10-31 Sale : show line 2 in the form −739 $12.88 $9,519 74,803 D
Open-market sales · 739 sh · avg $12.88 · $9,519

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −2,886 37,519 D
Loading xslF345X03/doc4.xml…